Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels-Reference-Cited by-同舟云学术

Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels

Published:2015-12-23 Issue:12 Volume:35 Page:1972-1984
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Żebrowska Magdalena¹,Posch Martin¹,Magirr Dominic¹

Affiliation:

1. Center for Medical Statistics, Informatics and Intelligent Systems Medical University of Vienna Vienna 1090 Austria

Funder

Austrian Science Fund

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.6848

Reference34 articles.

1. ICH Topic E9: Notes for guidance on statistical principles for clinical trials European Agency for the Evaluation of Medical Products:London UK 1998.

2. Designed Extension of Studies Based on Conditional Power

3. Maximum inflation of the type 1 error rate when sample size and allocation rate are adapted in a pre-planned interim look

4. Evaluation of Experiments with Adaptive Interim Analyses

5. Issues in designing flexible trials

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bi-endpoint expectation-maximisation algorithm for re-estimating sample size for the time-to-event endpoint under the blind condition;Journal of the Royal Statistical Society Series C: Applied Statistics;2024-05-07

2. Preventing Respiratory Viral Illness Invisibly (PRiVII): protocol for a pragmatic cluster randomized trial evaluating far-UVC light devices in long-term care facilities to reduce infections;Trials;2024-01-26

3. Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023;Current Pain and Headache Reports;2023-12-14

4. Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency;Trials;2018-11-20

5. Adaptive designs in clinical trials: why use them, and how to run and report them;BMC Medicine;2018-02-28